1,201 Shares in Cardinal Health, Inc. $CAH Bought by Cobblestone Capital Advisors LLC NY

Cobblestone Capital Advisors LLC NY bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,201 shares of the company’s stock, valued at approximately $202,000.

Several other institutional investors have also bought and sold shares of the business. MassMutual Private Wealth & Trust FSB lifted its position in Cardinal Health by 3.6% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock valued at $297,000 after purchasing an additional 62 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its holdings in shares of Cardinal Health by 0.4% in the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock worth $2,991,000 after acquiring an additional 69 shares during the last quarter. Perigon Wealth Management LLC lifted its position in shares of Cardinal Health by 3.2% during the second quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock worth $389,000 after purchasing an additional 72 shares during the last quarter. Community Bank & Trust Waco Texas lifted its position in shares of Cardinal Health by 1.3% during the second quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock worth $940,000 after purchasing an additional 74 shares during the last quarter. Finally, Atlantic Edge Private Wealth Management LLC lifted its holdings in Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after buying an additional 75 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Insider Activity

In other news, CEO Stephen M. Mason sold 41,575 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the transaction, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the transaction, the insider directly owned 15,431 shares in the company, valued at approximately $2,298,293.14. The trade was a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock worth $40,489,525 over the last 90 days. 0.12% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

CAH has been the subject of a number of research analyst reports. Robert W. Baird lifted their price objective on shares of Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a report on Wednesday, August 13th. Jefferies Financial Group set a $150.00 price target on shares of Cardinal Health in a research note on Tuesday, August 12th. Argus set a $189.00 target price on Cardinal Health in a research report on Friday, August 22nd. Wells Fargo & Company reaffirmed an “overweight” rating and set a $185.00 target price (up from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Finally, Evercore ISI decreased their target price on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research report on Wednesday, August 13th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $166.00.

Cardinal Health Trading Up 1.2%

CAH opened at $163.76 on Tuesday. The firm has a market cap of $38.91 billion, a price-to-earnings ratio of 25.39, a PEG ratio of 1.37 and a beta of 0.71. Cardinal Health, Inc. has a 12 month low of $106.98 and a 12 month high of $168.44. The stock has a fifty day moving average price of $153.04 and a 200-day moving average price of $153.26.

Cardinal Health (NYSE:CAH) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm’s revenue was up .5% on a year-over-year basis. During the same period in the previous year, the company posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.2%. The ex-dividend date was Wednesday, October 1st. Cardinal Health’s payout ratio is 31.63%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.